PHAP names new president

MANILA, Philippines — The Pharmaceutical and Healthcare Association of the Philippines (PHAP) has named Dr. Diana Edralin as its new president who will lead the group in facilitating the rollout of new medicines in the country.

In a statement, PHAP  said Edralin, the general manager of Roche Philippines, replaced former president Dr. Beaver Tamesis, who will now serve as chairman emeritus of the organization.

As the new leader of the 42-member strong pharmaceutical group, Edralin vowed to promote innovation and strengthen their partnership with the government as the country recovers from the pandemic and prepares for future health threats.

“We have witnessed that the health of the nation is crucial to its social and economic progress. Due to its wider implications, health should be prioritized. Public and private investments and collaborations to strengthen the healthcare system will be crucial as we navigate our way out of the pandemic, and prepare for any future health concerns,” she said.

As a science-driven organization, she said the PHAP can work with the government in ensuring innovative and life-saving medicines and vaccines are available to patients when needed.

With lessons learned from the ongoing pandemic, she said the group would also work on bringing new medicines in the country to improve the health of Filipinos.